Endobronchial valves in severe emphysematous patients: CT evaluation of lung fissures completeness, treatment radiological response and quantitative emphysema analysis

Abstract

OBJECTIVE: To evaluate lung fissures completeness, post-treatment radiological response and quantitative CT analysis (QCTA) in a population of severe emphysematous patients submitted to endobronchial valves (EBV) implantation. MATERIALS AND METHODS: Multi-detectors CT exams of 29 patients were studied, using thin-section low dose protocol without contrast. Two radiologists retrospectively reviewed all images in consensus; fissures completeness was estimated in 5% increments and post-EBV radiological response (target lobe atelectasis/volume loss) was evaluated. QCTA was performed in pre and post-treatment scans using a fully automated software. RESULTS: CT response was present in 16/29 patients. In the negative CT response group, all 13 patients presented incomplete fissures, and mean oblique fissures completeness was 72.8%, against 88.3% in the other group. QCTA most significant results showed a reduced post-treatment total lung volume (LV) (mean 542 ml), reduced EBV-submitted LV (700 ml) and reduced emphysema volume (331.4 ml) in the positive response group, which also showed improved functional tests. CONCLUSION: EBV benefit is most likely in patients who have complete interlobar fissures and develop lobar atelectasis. In patients with no radiological response we observed a higher prevalence of incomplete fissures and a greater degree of incompleteness. The fully automated QCTA detected the post-treatment alterations, especially in the treated lung analysis.

Quantitative computed tomography analysis of the airways in patients with cystic fibrosis using automated software: correlation with spirometry in the evaluation of severity

“…Primarily in the study of chronic obstructive pulmonary disease and asthma, the quantitative analysis of CT scans, done automatically or semi-automatically, has shown good accuracy and good correlation with functional tests (19-22) . In attempts to standardize imaging evaluation of CF, various visual grading systems (scores) have been devised for use in plain radiography, CT, and MRI.…”

Artificial intelligence, machine learning, computer-aided diagnosis, and radiomics: advances in imaging towards to precision medicine

“…The discipline of radiology and diagnostic imaging has evolved greatly in recent years. Radiological imaging can be extremely complex, and it is recognized that the analysis of exams that produce hundreds of images, such as computed tomography (CT) and magnetic resonance imaging (MRI), poses challenges, even for experienced provide quantitative information on disease severity, as well as identifying biomarkers of prognosis and treatment response (4)(5)(6) . Those changes have been especially prominent in oncology, showing that the information provided by imaging studies can go far beyond determining whether a lesion is benign or malignant, now being able to indicate the histological type of the tumor, staging, presence of mutations, chance of treatment response, risk of recurrence, and expected survival (7)(8)(9) .…”

Computed Tomography as a Biomarker in Clinical Trials Imaging

“…In these same studies, QCT measurement of lung density as an index of parenchymal destruction is often used to both confirm disease presence and enrich the target populations on the basis of the amount and distribution of emphysema. 64,66 There are many emerging markers of COPD, including airway wall measures, air trapping, regional volume change, and vessel volume that are in early phases of development and analytic development. Another potential novel biomarker emerged in the first trial of such treatments in which collateral flow into a putative treatment lobe from an adjacent lobe is a strong predictive indicator of treatment failure.…”